Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
0(0%)
Results Posted
33%(3 trials)

Phase Distribution

Ph phase_1
2
17%
Ph phase_2
5
42%
Ph not_applicable
4
33%
Ph phase_4
1
8%

Phase Distribution

2

Early Stage

5

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
5(41.7%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
4(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(9)
Other(1)

Detailed Status

Completed9
Not yet recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (16.7%)
Phase 25 (41.7%)
Phase 41 (8.3%)
N/A4 (33.3%)

Trials by Status

completed975%
not_yet_recruiting217%
unknown18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
DRUG
Total Trials
12